Evaluation of the Irritation Potential of Products in Human Eyes
NCT02714166 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2017-03-30
Summary
To evaluate the human eye irritation potential of one test sunscreen formulation.
Conditions
- Sunscreening Agents
Interventions
- OTHER
-
Sunscreen lotion SPF (Sun Protection Factor) 50 (BAY987521)
Study staff will administer the control in one eye and a test sunscreen in the other eye according to the assigned randomization schedule.
- OTHER
-
Ophthalmic Ointment
Study staff will administer the control in one eye and a test sunscreen in the other eye according to the assigned randomization schedule.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-02-26
- Primary Completion
- 2016-02-26
- Completion
- 2016-02-26
Countries
- United States
Study Locations
More Related Trials
-
To Evaluate Eye Installation-Tear Free
NCT02802917 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating Safety of BT01001 Ophthalmic Solution
NCT07313722 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis
NCT00586664 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
NCT00349466 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT02242032 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy Volunteers
NCT06978244 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1
NCT02597803 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers
NCT00586625 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
NCT05865379 ·Status: RECRUITING ·Phase: NA
-
Systemic Pharmacokinetics of BOL-303224-A
NCT00407589 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
NCT02831387 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis
NCT05591755 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease
NCT04734197 ·Status: COMPLETED ·Phase: PHASE2
-
Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
NCT03925727 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia
NCT00383396 ·Status: COMPLETED ·Phase: PHASE4
-
Ocular Comfort and Inflammation in Lid Hygiene Therapy
NCT02938078 ·Status: TERMINATED ·Phase: NA
-
Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical Instillation
NCT00905762 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
NCT02688556 ·Status: COMPLETED ·Phase: PHASE3
-
The Evaluation of Bepreve on the Measurement of Wheal and Flare Response From Histamine Skin Prick Testing
NCT01128556 ·Status: COMPLETED ·Phase: PHASE4
-
Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
NCT00037661 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
NCT02824913 ·Status: TERMINATED ·Phase: PHASE2
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality
NCT00622037 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01468168 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome
NCT03162783 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
NCT07217678 ·Status: RECRUITING ·Phase: PHASE4